SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-151658
Filing Date
2017-05-01
Accepted
2017-05-01 15:42:03
Documents
7
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A d343581ddefa14a.htm DEFA14A 43073
2 GRAPHIC g343581notacc1a.jpg GRAPHIC 5005
3 GRAPHIC g343581notacc1b.jpg GRAPHIC 2764
4 GRAPHIC g343581notacc2a.jpg GRAPHIC 3355
5 GRAPHIC g343581notacc2b.jpg GRAPHIC 2762
6 GRAPHIC g343581notacc3.jpg GRAPHIC 2765
7 GRAPHIC g343581notacc4.jpg GRAPHIC 2765
  Complete submission text file 0001193125-17-151658.txt   71810
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 17800474
SIC: 2834 Pharmaceutical Preparations